Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 4;8(11):1867.
doi: 10.3390/jcm8111867.

Secretome and Extracellular Vesicles as New Biological Therapies for Knee Osteoarthritis: A Systematic Review

Affiliations
Review

Secretome and Extracellular Vesicles as New Biological Therapies for Knee Osteoarthritis: A Systematic Review

Daniele D'Arrigo et al. J Clin Med. .

Abstract

Secretome and extracellular vesicles (EVs) are considered a promising option to exploit mesenchymal stem cells' (MSCs) properties to address knee osteoarthritis (OA). The aim of this systematic review was to analyze both the in vitro and in vivo literature, in order to understand the potential of secretome and EVs as a minimally invasive injective biological approach. A systematic review of the literature was performed on PubMed, Embase, and Web of Science databases up to 31 August 2019. Twenty studies were analyzed; nine in vitro, nine in vitro and in vivo, and two in vivo. The analysis showed an increasing interest in this emerging field, with overall positive findings. Promising in vitro results were documented in terms of enhanced cell proliferation, reduction of inflammation, and down-regulation of catabolic pathways while promoting anabolic processes. The positive in vitro findings were confirmed in vivo, with studies showing positive effects on cartilage, subchondral bone, and synovial tissues in both OA and osteochondral models. However, several aspects remain to be clarified, such as the different effects induced by EVs and secretome, which is the most suitable cell source and production protocol, and the identification of patients who may benefit more from this new biological approach for knee OA treatment.

Keywords: Exosome; extracellular vesicles; injection; knee osteoarthritis; mesenchymal stem cell.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) flowchart of the systematic literature review.
Figure 2
Figure 2
Schematic representation of secretome components.
Figure 3
Figure 3
Published preclinical articles per year.

References

    1. van der Kraan P.M., van den Berg W.B. Osteoarthritis in the context of ageing and evolution. Loss of chondrocyte differentiation block during ageing. Ageing Res. Rev. 2008;7:106–113. doi: 10.1016/j.arr.2007.10.001. - DOI - PubMed
    1. Aigner T., Rose J., Martin J., Buckwalter J. Aging theories of primary osteoarthritis: From epidemiology to molecular biology. Rejuvenation Res. 2004;7:134–145. doi: 10.1089/1549168041552964. - DOI - PubMed
    1. Jafarzadeh S.R., Felson D.T. Updated Estimates Suggest a Much Higher Prevalence of Arthritis in United States Adults than previous ones. Arthritis Rheumatol. 2018;70:185–192. doi: 10.1002/art.40355. - DOI - PMC - PubMed
    1. Farr J., II, Miller L.E., Block J.E. Quality of life in patients with knee osteoarthritis: A commentary on nonsurgical and surgical treatments. Open Orthop. J. 2013;7:619–623. doi: 10.2174/1874325001307010619. - DOI - PMC - PubMed
    1. Deshpande B.R., Katz J.N., Solomon D.H., Yelin E.H., Hunter D.J., Messier S.P., Suter L.G., Losina E. Number of Persons With Symptomatic Knee Osteoarthritis in the US: Impact of Race and Ethnicity, Age, Sex, and Obesity. Arthritis Care Res. 2016;68:1743–1750. doi: 10.1002/acr.22897. - DOI - PMC - PubMed